Short answer
Immunome Inc. (IMNM) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders elected James Boylan, Sandra Swain, M.D., and Philip Wagenheim as Class III directors through 2029.
Immunome Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders elected James Boylan, Sandra Swain, M.D., and Philip Wagenheim as Class III directors through 2029
- Boylan received 70,209,570 votes for versus 22,171,996 withheld, signaling notable shareholder opposition
- Ernst & Young LLP appointment ratified for fiscal 2026 with 104,100,900 votes for
- Executive compensation approved advisory with 90,908,436 votes for
- Annual advisory votes on executive compensation adopted, receiving 91,949,591 votes for one-year frequency
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Immunome Inc. 8-K filings
Get the next IMNM 8-K as it lands
Follow IMNM for push alerts, or ask the research agent what this filing means.